Salvage lymph node dissection for prostate-specific membrane antigen (PSMA) positron emission tomography (PET)-identified oligometastatic disease
Canadian Urological Association Journal2021Vol. 15(10), pp. E545–E552
Citations Over Time
Adam Bobrowski, Ur Metser, Antonio Finelli, Neil Fleshner, Alejandro Berlín, Nathan Perlis, Girish S. Kulkarni, Peter Chung, Kopika Kuhathaas, Eshetu G. Atenafu, Robert J. Hamilton
Abstract
In our series of salvage dissection for PSMA-PET-detected nodal oligometastases, approximately a third achieved PSA <0.2; yet, it was only durable in 27%. Prospective trials of salvage nodal radiation are ongoing, however, more prospective trials of salvage node dissection are needed.
Related Papers
- → Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy(2018)328 cited
- → Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes(2014)22 cited
- → Prostate Cancer Biochemical Recurrence Resulted Negative on [68Ga]Ga-PSMA-11 but Positive on [18F]Fluoromethylcholine PET/CT(2022)13 cited
- → Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer(2009)31 cited
- → Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer(2014)10 cited